Cancer Options Blog

This blog is a way of sharing, supporting and educating anyone dealing with a cancer-related illness about the options and treatments they have at their disposal.

You're browsing: Home » Blog » News » Blog article: Doctors rethink treatment for prostate cancer in older men

Doctors rethink treatment for prostate cancer in older men

This Article was Written November 7th, 2008

Powered by Gregarious (39)

With increasing life expectancies, improved surgical tools and better information on patient results, many older men diagnosed with early prostate cancer are taking a pass on the traditional advice to hold off on treatment for a period of time.

Such “watchful waiting” - or closely monitoring the cancer’s progression - is still a viable option. But many experts now believe aggressive treatment - even for older men - may be the better way to go.

“We’re pushing the limits on the upper end,” says Dr. Edouard J. Trabulsi, assistant professor in the department of urology at Jefferson Medical College and co-director of the Jefferson Prostate Diagnostic Center in Philadelphia.

A study published recently in the Journal of the American Medical Association helped shake up the conventional wisdom. The study, which involved some 44,000 men, found that the death risk for those who received prostate cancer treatment was nearly one-third lower than for men who received no treatment. And that was true across all age categories, including the oldest men in the study, aged 75 to 80.

“We often think of prostate cancer as an indolent disease, and it is for many men, which is why observation is a very reasonable treatment option for patients with low and intermediate risk disease,” said the study’s lead author, Dr. Yu-Ning Wong, a medical oncologist at the Fox Chase Cancer Center in Philadelphia.

“However, the life expectancy for a 70-year-old man is about 13 years and patients who are otherwise healthy should recognize that if they live long enough, they may be at risk of developing complications from prostate cancer,” she added.

Prostate cancer is the second most common type of cancer in American men, after skin cancer. In 2008, about 186,320 new cases of the disease will be diagnosed, and about 28,660 men will die from it, according to the American Cancer Society.

Because prostate cancer is generally a slow-growing cancer, some men may never need treatment. And for many older men without symptoms, watchful waiting has been recommended because it was believed they would die from other causes before their cancer advanced.

But as men’s life expectancy creeps higher and new robotic techniques improve the precision of surgery, the decision is becoming more complicated.

“Patients should understand the risks and benefits of all their treatment options - radiation, surgery and observation,” Wong said. “If they choose observation, they should be committed to careful follow-up with their physicians.”

Watchful waiting does not mean watching someone die. Many oncologists today prefer the term “active surveillance,” Trabulsi says, because it more accurately describes the diligent approach to monitoring these patients, including the use of prostate specific antigen, or PSA, blood tests, digital rectal exams and biopsies of the prostate to detect changes in the cancer.

Still, determining the best course of treatment is difficult, because there isn’t good data to help guide patients and their families on the effectiveness and harms of treatments for clinically localized prostate cancer, according to a recent literature review prepared for the federal Agency for Healthcare Research and Quality.

But oncologists hope to have better information on the benefits and risks of active surveillance, also known as “expectant management,” compared with treatment by late next year. The National Cancer Institute and the Department of Veterans Affairs are co-sponsoring a study called the “prostate cancer intervention versus observation trial,” to compare radical prostatectomy - which is removal of the gland - and expectant management on patient survival and overall quality of life.

 Source: Karen Pallarito • Gannett News Service • November 7, 2008

Powered by Gregarious (39)

PLEASE post a comment below

  • Categories

  • Subscribe

    All posts by all authors Google Reader or Homepage Subscribe Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online Add to My AOL Subscribe in Rojo Add to Technorati Favorites!
    Business Blogs - BlogCatalog Blog Directory

    Enter your email address:

    Comments (RSS)

  • Random Posts & Pages

    Why Some Prostate Cancer Returns

  • Why Some Prostate Cancer Returns The majority of men who receive one of the standard treatments for localized prostate cancer - surgery or radiation therapy - have an excellent outcome.But for the small group whose prostate cancer returns, a new study offers insight as to why treatment isn't effective. The study -
  • Risk For Aggressive Prostate Cancer Increased By Gene Mutations

  • Risk For Aggressive Prostate Cancer Increased By Gene Mutations Main Category: Prostate / Prostate Cancer Also Included In: Genetics Article Date: 30 Jan 2009 - 3:00 PST Men who develop prostate cancer face an increased risk of having an aggressive tumor if they carry a so-called breast cancer gene mutation, scientists from the Albert Einstein
  • Cardiac Deaths Do Not Appear To Be Increased By Hormone Therapy For Prostate Cancer

  • Treating prostate cancer patients with drugs that block hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study led by Massachusetts General Hospital (MGH) researchers. While a 2006 report from members of the same study team found that treatment with gonadotropin-releasing hormone
  • Strikeout prostate cancer

  •  About one in six men is diagnosed with prostate cancer. If it's caught early, the cancer is almost 100-percent curable, but if it goes undetected, it can be deadly. So now a new campaign is raising money and getting guys attention . . . with America's favorite pasttime. As major league
  • Prostate Cancer Hormone Therapy Treatment Questioned

  • Hormone therapy, an aggressive treatment for prostate cancer, may be overused, a new study suggests.Treatment used to reduce the size of the prostate has been shown to improve survival in advanced cancers, but doctors have increasingly been giving hormone therapy in less-severe cases. The study, published in this week's New England
  • Family History Of Prostate Cancer Does Not Affect Some Treatment Outcomes

  • Family History Of Prostate Cancer Does Not Affect Some Treatment Outcomes ScienceDaily (Jan. 2, 2009) — In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated with brachytherapy (also called seed implants), and patients with this
  • Sound Waves Treat Prostate Cancer With Fewer Side Effects

  • Sound Waves Treat Prostate Cancer With Fewer Side Effects An Experimental cancer therapy for prostate cancer may be able to treat men without surgery and offer fewer side effects according to the results of a UK study published in the British Journal of Cancer* today (Wednesday).A group of 172 men with prostate
  • ASTRO’s 49th annual meeting of radiation oncology

  • ProxcelanTM (Cesium-131) is the newest advancement in permanent brachytherapy seed implants for prostate cancerLOS ANGELES, CA - Several newly released scientific findings focusing on various aspects of ProxcelanTM (Cesium-131) seeds' effectiveness in the treatment of prostate cancer--supporting and broadening the growing body of evidence on the newest medical isotope being
  • New Lab Evidence Suggests Preventive Effect of Herbal Supplement in Prostate Cancer

  • New Lab Evidence Suggests Preventive Effect Of Herbal Supplement In Prostate Cancer ScienceDaily (Feb. 23, 2009) — DHEA is a natural circulating hormone and the body's production of it decreases with age. Men take DHEA as an over-the-counter supplement because it has been suggested that DHEA can reverse aging or have anabolic effects
  • Green Tea Component May Slow Prostate Cancer

  • Green Tea Component May Slow Prostate Cancer Men in small study took capsules equivalent to brewed beverage Friday, June 19 (HealthDay News) -- The active compounds in green tea might slow the progression of prostate cancer, the results of a small study suggest. The study included 26 men, 41 to 72 years old,


  •  

    July 2010
    M T W T F S S
    « Jan    
     1234
    567891011
    12131415161718
    19202122232425
    262728293031